# Editorial: The future of modern medicine: cells, scaffolds, and biofactors

**Authors:** Laila A. Damiati, Daniel Durand-Herrera, Marwa El Soury

PMC · DOI: 10.3389/fmed.2024.1434760 · Frontiers in Medicine · 2024-06-27

## Full-text entities

- **Genes:** TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, TGFB3 (transforming growth factor beta 3) [NCBI Gene 7043] {aka ARVD, ARVD1, LDS5, RNHF, TGF-beta3}, NTF3 (neurotrophin 3) [NCBI Gene 4908] {aka HDNF, NGF-2, NGF2, NT-3, NT3}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, GDNF (glial cell derived neurotrophic factor) [NCBI Gene 2668] {aka ATF, ATF1, ATF2, HFB1-GDNF, HSCR3}, NGF (nerve growth factor) [NCBI Gene 4803] {aka Beta-NGF, HSAN5, NGFB}, FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}
- **Diseases:** pancreatic ductal adenocarcinoma (MESH:D021441), bone fractures (MESH:D050723), Pancreatic cancer (MESH:D010190), inflammation (MESH:D007249), pain (MESH:D010146), lower back pain (MESH:D017116), cancer-associated (MESH:D009369), IVDD (MESH:D055959), Metastasis (MESH:D009362), bone injuries (MESH:D001847), DD-H (MESH:D000848), damage (MESH:D020263)
- **Chemicals:** calcium (MESH:D002118), gemcitabine (MESH:D000093542)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** DD-H — Homo sapiens (Human), Blast phase chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_J651)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11236726/full.md

---
Source: https://tomesphere.com/paper/PMC11236726